[HTML][HTML] COVID-19: Integrating the complexity of systemic and pulmonary immunopathology to identify biomarkers for different outcomes

TFC Fraga-Silva, SR Maruyama, CA Sorgi… - Frontiers in …, 2021 - frontiersin.org
In the last few months, the coronavirus disease 2019 (COVID-19) pandemic has affected
millions of people worldwide and has provoked an exceptional effort from the scientific …

COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes

TF de Campos Fraga-Silva, SR Maruyama… - FRONTIERS IN …, 2021 - bv.fapesp.br
In the last few months, the coronavirus disease 2019 (COVID-19) pandemic has affected
millions of people worldwide and has provoked an exceptional effort from the scientific …

[HTML][HTML] COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes

TFC Fraga-Silva, SR Maruyama, CA Sorgi… - Frontiers in …, 2021 - frontiersin.org
In the last few months, the coronavirus disease 2019 (COVID-19) pandemic has affected
millions of people worldwide and has provoked an exceptional effort from the scientific …

COVID-19: integrating the complexity of systemic and pulmonary immunopathology to identify biomarkers for different outcomes.

TFC Fraga-Silva, SR Maruyama, CA Sorgi, EMS Russo… - 2021 - cabidigitallibrary.org
In the last few months, the coronavirus disease 2019 (COVID-19) pandemic has affected
millions of people worldwide and has provoked an exceptional effort from the scientific …

COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes

TF de Campos Fraga-Silva… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
In the last few months, the coronavirus disease 2019 (COVID-19) pandemic has affected
millions of people worldwide and has provoked an exceptional effort from the scientific …

[HTML][HTML] COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes

TF de Campos Fraga-Silva, SR Maruyama… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
In the last few months, the coronavirus disease 2019 (COVID-19) pandemic has affected
millions of people worldwide and has provoked an exceptional effort from the scientific …

COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes.

TFC Fraga-Silva, SR Maruyama, CA Sorgi… - Frontiers in …, 2021 - europepmc.org
In the last few months, the coronavirus disease 2019 (COVID-19) pandemic has affected
millions of people worldwide and has provoked an exceptional effort from the scientific …

[PDF][PDF] COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes

TFC Fraga-Silva, SR Maruyama, CA Sorgi… - Front. Immunol. 11 …, 2021 - repositorio.usp.br
In the last few months, the coronavirus disease 2019 (COVID-19) pandemic has affected
millions of people worldwide and has provoked an exceptional effort from the scientific …

[引用][C] COVID-19: integrating the complexity of systemic and pulmonary immunopathology to identify biomarkers for different outcomes

TFC Fraga-Silva, SR Maruyama, CA Sorgi… - Frontiers in …, 2021 - repositorio.usp.br
USP affiliated authors: SORGI, CARLOS ARTERIO-FFCLRP; RUSSO, ELISA MARIA DE
SOUSA-FCFRP; FERNANDES, ANA PAULA MORAIS-EERP; CARDOSO, CRISTINA …

COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes.

TFC Fraga-Silva, SR Maruyama, CA Sorgi… - Frontiers in …, 2021 - europepmc.org
In the last few months, the coronavirus disease 2019 (COVID-19) pandemic has affected
millions of people worldwide and has provoked an exceptional effort from the scientific …